KLRK1 and Miyoshi myopathy: In 9 out of 10 cases, our target cells were found to be positive for NKG2D, based on these findings, we assumed that these cells may participate in antitumor immune responses which, in turn could be crucial in achieving long term disease control in MM patients (11).